The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Molipaxin 150mg Film-coated Tablets



Neuraxpharm Ireland LimitedPA23229/011/003

Main Information

Trade NameMolipaxin 150mg Film-coated Tablets
Active SubstancesTrazodone hydrochloride
Dosage FormFilm-coated tablet
Licence HolderNeuraxpharm Ireland Limited
Licence NumberPA23229/011/003

Group Information

ATC CodeN06AX Other antidepressants
N06AX05 trazodone

Status

License statusAuthorised
Licence Issued02/12/1985
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back